Emerging Biosimilars in Therapeutics

The main theme of this track is to have sound knowledge in the emerging biosimilar products like Recombinant blood products, therapeutic proteins, vaccines, Growth hormones, Biosimilar peptides, therapeutic proteins, biosimilar antibodies.Biosimilar insulins are the most expected ones in the class to enter the biosimilar landscape as patents for major branded insulin products start to expire in the next few years

The proportion of different biosimilars that reached market are Low Molecular Weight Heparins 44%, Epoetins 19%, HGH 11%, G-CSFs 7%, Interferons 6%, Insulins 5%, Others 8%.

  • Recombinant blood products
  • Biosimilars interferon
  • Biosimilar monoclonal antibodies
  • Biosimilars in cancer treatment
  • Recombinant therapeutic proteins
  • Biosimilar peptides
  • Insulin Biosimilars
  • Growth hormones
  • Recombinant vaccines
  • Biosimilars in rheumatic diseases

Related Conference of Emerging Biosimilars in Therapeutics

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Emerging Biosimilars in Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in